Genetic Testing Helps Identify Ovarian Cancer Patients with BRCA Mutations, UK Study Finds

Genetic Testing Helps Identify Ovarian Cancer Patients with BRCA Mutations, UK Study Finds
Genetic testing as part of routine cancer care, an approach called mainstreamed genetic testing, or MGT, is a feasible way to test BRCA mutations in ovarian cancer patients, a new U.K. study reports. For those who tested positive, a relevant proportion of patients accessed targeted treatment they wouldn’t otherwise be eligible to receive. The study, “Mainstreamed genetic

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *